# Steven A. Feldman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/steven-a-feldman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,934 |
| Field | CAR-T cell therapy research |
| h-index | 52 |
| i10-index | 89 |
| Last Known Institution | Stanford University |
| OpenAlex ID | https://openalex.org/A5032315182 |
| ORCID iD | https://orcid.org/0000-0003-2098-3860 |
| Works | 254 |

## Researcher papers

- [T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial](https://scholariq.org/papers/t-cells-expressing-cd19-chimeric-antigen-receptors-for-acute-lymphoblastic/)
- [Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1](https://scholariq.org/papers/tumor-regression-in-patients-with-metastatic-synovial-cell-sarcoma-and-melanoma/)
- [Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor](https://scholariq.org/papers/chemotherapy-refractory-diffuse-large-b-cell-lymphoma-and-indolent-b-cell/)
- [Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19](https://scholariq.org/papers/eradication-of-b-lineage-cells-and-regression-of-lymphoma-in-a-patient-treated/)
- [A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response](https://scholariq.org/papers/a-pilot-trial-using-lymphocytes-genetically-engineered-with-an-ny-eso-1-reactive/)
- [Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma](https://scholariq.org/papers/pilot-trial-of-adoptive-transfer-of-chimeric-antigen-receptor-transduced-t-cells/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research-2/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Viral Infectious Diseases and Gene Expression in Insects](https://scholariq.org/topics/viral-infectious-diseases-and-gene-expression-in-insects-2/)

## Researcher university

- [Stanford University](https://scholariq.org/institutions/stanford-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.